Takakura Y, Fujita T, Hashida M, Sezaki H
Department of Basic Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Pharm Res. 1990 Apr;7(4):339-46. doi: 10.1023/a:1015807119753.
As part of the strategy for the design of macromolecular carriers for drug targeting, the disposition characteristics of macromolecules were studied in mice bearing tumors that served as target tissues. Eight kinds of macromolecules including four polysaccharides and four proteins with different molecular weights and electric charges were used; tissue distribution and tumor localization after intravenous injection were studied. Pharmacokinetic analysis revealed that the tissue radioactivity uptake rate index calculated in terms of clearance was different among the tested compounds; especially, the urinary radioactivity excretion clearances and the total hepatic radioactivity uptake clearances varied widely. Compounds with low molecular weights (approximately 10 kD) or positive charges showed lower tumor radioactivity accumulation; radioactivity was rapidly eliminated from the plasma via rapid urinary excretion or extensive hepatic uptake, respectively. On the other hand, large and negatively charged compounds, carboxymethyl dextran, bovine serum albumin, and mouse immunoglobulin G, showed higher radioactivity accumulation in the tumor (calculated total amounts were 15.6, 10.8, and 20.8% of the dose, respectively) and prolonged retention in the circulation. These results demonstrated that the total systemic exposure rather than the uptake rate index was correlated with total tumor uptake. Molecular weight and electric charge of the macromolecules significantly affected their disposition characteristics and, consequently, determined radioactivity accumulation in the tumor. It was concluded that a drug-carrier complex designed for systemic tumor targeting should be polyanionic in nature and larger than 70,000 in molecular weight.
作为设计用于药物靶向的大分子载体策略的一部分,在作为靶组织的荷瘤小鼠中研究了大分子的处置特征。使用了包括四种多糖和四种具有不同分子量和电荷的蛋白质在内的八种大分子;研究了静脉注射后的组织分布和肿瘤定位。药代动力学分析表明,根据清除率计算的组织放射性摄取率指数在受试化合物之间存在差异;特别是,尿放射性排泄清除率和肝脏总放射性摄取清除率差异很大。低分子量(约10kD)或带正电荷的化合物显示出较低的肿瘤放射性积累;放射性分别通过快速尿排泄或广泛的肝脏摄取从血浆中迅速消除。另一方面,大的带负电荷的化合物,羧甲基葡聚糖、牛血清白蛋白和小鼠免疫球蛋白G,在肿瘤中显示出较高的放射性积累(计算总量分别为剂量的15.6%、10.8%和20.8%),并且在循环中的保留时间延长。这些结果表明,全身总暴露而非摄取率指数与肿瘤总摄取相关。大分子的分子量和电荷显著影响其处置特征,因此决定了肿瘤中的放射性积累。得出的结论是,设计用于全身肿瘤靶向的药物载体复合物在性质上应为聚阴离子,分子量应大于70,000。